Search results
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 5 days agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs ...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 4 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 5 days agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 4 days ago[and] we do not believe that COVID upside alone ... is enough to drive shares higher in the...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 3 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company ...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 5 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 ...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 4 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 4 days agoPfizer Chief Executive Albert Bourla said in an interview Wednesday he was encouraged but that the company's stock is undervalued.
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 2 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca ...